Corline Biomedical

Corline Biomedical Diluted EPS

The Diluted Earnings per Share of Corline Biomedical (CLBIO.ST) as of Oct 24, 2026 is -0.58 SEK. In the previous year, Diluted Earnings per Share was -1.02 SEK — a change of -43.26% (higher).

Diluted EPS

-0.58SEK

YoY

-43.26%

Last updated:

Diluted Earnings per Share of Corline Biomedical is 2025 -0.58 SEK. Diluted Earnings per Share of Corline Biomedical was 2024 -1.02 SEK. It decreases by -43.26% higher compared to the previous year.

The Corline Biomedical Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-0.42 SEK
Jan 1, 2019
-0.56 SEK
Jan 1, 2020
-0.42 SEK
Jan 1, 2021
-0.34 SEK
Jan 1, 2022
0.11 SEK
Jan 1, 2023
-0.08 SEK
Jan 1, 2024
-1.02 SEK
Jan 1, 2025
-0.58 SEK
The Corline Biomedical Diluted EPS history
YEARDiluted EPSYoY
-0.58SEK-43.26%
-1.02SEK+1,109.77%
-0.08SEK-177.67%
0.11SEK-132.03%
-0.34SEK-20.38%
-0.42SEK-23.62%
-0.56SEK+32.39%
-0.42SEK-28.37%
-0.59SEK+46.49%
-0.40SEK-31.95%
-0.59SEK+56.56%
-0.38SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical AB, headquartered in Uppsala, Sweden, operates in the Health Care sector, specifically within Pharmaceuticals. The company focuses on the research, development, and commercialization of heparin-based solutions for kidney transplantation, cell therapies, and regenerative medicine applications. Listed on 3 June 2015, Corline Biomedical employs eight people and is dedicated to advancing medical treatments through innovative heparin-based technologies. Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

Diluted Earnings per Share of Corline Biomedical is -0.58 SEK in 2025.

Diluted Earnings per Share of Corline Biomedical changed from -1.02 SEK to -0.58 SEK, representing a -43.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Corline Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Corline Biomedical